# FDA Inspection 1121022 - Cosmax USA, Inc. - March 17, 2020

Source: https://www.keypedia.com/records/fda_inspections/cosmax-usa-inc/a72891d7-2acd-4b32-aa23-14c54abaf0ad
Source feed: FDA_Inspections

> FDA Inspection 1121022 for Cosmax USA, Inc. on March 17, 2020. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1121022
- Company Name: Cosmax USA, Inc.
- Inspection Date: 2020-03-17
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1281580 - 2025-09-12](https://www.keypedia.com/records/fda_inspections/cosmax-usa-inc/058edd0b-2212-410e-aba0-1da3ccd88361)
- [FDA Inspection 1177107 - 2022-07-22](https://www.keypedia.com/records/fda_inspections/cosmax-usa-inc/850d8fd8-76c9-4059-b754-0416aa25548d)
- [FDA Inspection 1099676 - 2019-07-25](https://www.keypedia.com/records/fda_inspections/cosmax-usa-inc/78415ea5-e1ef-4007-8b22-7103f30e5d55)
- [FDA Inspection 1025842 - 2017-09-20](https://www.keypedia.com/records/fda_inspections/cosmax-usa-inc/28fba0e5-785b-44d0-9291-faa96f2941b2)
- [FDA Inspection 1019816 - 2017-06-16](https://www.keypedia.com/records/fda_inspections/cosmax-usa-inc/71baae49-dda4-46ee-b6bd-73c09e576a28)

Company: https://www.keypedia.com/companies/cosmax-usa-inc/07864b04-8b51-48e2-9b98-690427e85a49

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c